Broadwood Capital
$1.9B 13F equity value
6 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Broadwood Capital covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| MNST | MONSTER BEVERAGE CORP NEW | 8,107,796 | $779M | 40.7% |
| STAA | STAAR SURGICAL CO | 16,123,842 | $463M | 24.2% |
| AXON | AXON ENTERPRISE INC | 693,504 | $389M | 20.3% |
| IWM | ISHARES TR | 474,920 | $143M | 7.5% |
| IMDX | INSIGHT MOLECULAR DIA INC | 12,684,884 | $75M | 3.9% |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 49,560,992 | $65M | 3.4% |
Track Broadwood Capital's 13F portfolio: $1.9B in reported holdings, 6 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}